跳至主要内容
临床试验/NCT02417194
NCT02417194Unknown不适用

Prospective Cohort Study for the Impact of Preoperative Glycemic Control Status Measured by HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Renal Cell Carcinoma

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 238 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
238
试验地点
1
主要终点
Fuhrman (nuclear) grade

研究概览

简要总结

The effect of preoperative glycemic control measured by HbA1c on renal cell carcinoma (RCC) outcome remains controversial. Thus, the investigators aim to examine the association of preoperative glycemic control with oncologic outcomes after radical or partial nephrectomy. The investigators will prospectively collect the relevant data including preoperative HbA1c in 238 patients of RCC patients undergoing nephrectomy. The associations between clinical variables and risk of adverse pathological features and disease recurrence will be tested using a multivariate logistic regression and multiple Cox-proportional hazards model, respectively.

详细描述

  • This is the observational study as the single institutional, prospective cohort study. The investigators prospectively collect the clinicopathological information of the patients with renal cell carcinoma (RCC) undergoing partial or radical nephrectomy.
  • Particularly, the investigators check the variables, including age at surgery, body mass index, sex, comorbidities, preoperative HbA1c levels, blood urea nitrogen (BUN)/creatinine levels, estimated-GFR, clinical TMN staging by CT scan, final pathological results (TMN stage, histology, and Fuhrman nuclear grade), warm ischemic time and surgical margin status (in the case of partial nephrectomy), postoperative recurrence and distant metastasis, renal function changes during follow-up periods.
  • The study protocol is same with routine follow-up schedule of the patients with RCC treated with nephrectomy. Typically, the investigators check the patients at 1, 3, 6, 12, 18, 24, 30 and 36 months. However, according to the patients status and preference, follow-up schedule can be changed within 3 months at specific time points. Because the present study is the observational cohort study, not intervention study, subtle changes of follow-up schedule would not affect on the primary outcomes.
  • Importantly, preoperative HbA1c should be checked within 1 month before operation, same as the routine preoperative laboratory tests.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Renal cell carcinoma (RCC) by image work-up such as CT scan
  • Clinically localized RCC
  • Aged over 20 years
  • Patients undergoing radical or partial nephrectomy

排除标准

  • distant metastasis, preoperatively
  • preoperative targeted therapy
  • preoperative immunotherapy
  • medications affecting glucose status other than diabetes mellitus

结局指标

主要结局

Fuhrman (nuclear) grade

时间窗: within 2 weeks after surgery

Pathological outcomes

Recurrence-free survival

时间窗: postoperative up to 3 years

Oncological outcome: recurrence-free survival

TMN stage

时间窗: within 2 weeks after surgery

Pathological outcomes

次要结局

  • Postoperative renal function as assessed by estimated glomerular filtration rate (GFR)(postoperative up to 3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sung Kyu Hong

Associate professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验

Prognostic Significance of Preoperative Hemoglobin... | 临床试验